| 1 | Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. (Zhang W, McIver AL, Stashko MA, DeRyckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X) J Med Chem 2013 Dec 12;56(23):9693-700 46 Citations |
| 1 | Upregulation of CB₁ receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. (McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB) Behav Brain Res 2013 Jan 15;237:333-7 56 Citations |
| 1 | Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. (Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS) Mol Psychiatry 2013 Oct;18(10):1125-35 200 Citations |
| 2 | Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. (Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, Hillard CJ) Neuroscience 2012 Mar 01;204:117-24 38 Citations |
| 1 | Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats. (Brozoski DT, Dean C, Hopp FA, Hillard CJ, Seagard JL) Auton Neurosci 2009 Oct 05;150(1-2):82-93 27 Citations |
| 1 | A case of venlafaxine-induced galactorrhea? (Wichman CL, Cunningham JL) J Clin Psychopharmacol 2008 Oct;28(5):580-1 9 Citations |
| 1 | Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. (Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, Gorzalka BB) J Neurochem 2008 Sep;106(6):2322-36 221 Citations |
| 1 | Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. (Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ) Hippocampus 2008;18(2):221-6 87 Citations |
| 1 | Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. (Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ) Neuropharmacology 2008 Jan;54(1):108-16 210 Citations |
| 1 | Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. (Rademacher DJ, Hillard CJ) Prog Neuropsychopharmacol Biol Psychiatry 2007 Apr 13;31(3):633-41 75 Citations |
| 1 | Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. (Hill MN, Ho WS, Meier SE, Gorzalka BB, Hillard CJ) Eur J Pharmacol 2005 Dec 28;528(1-3):99-102 36 Citations |
| 1 | Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. (Patel S, Cravatt BF, Hillard CJ) Neuropsychopharmacology 2005 Mar;30(3):497-507 140 Citations |
| 1 | Cannabinoid-induced Fos expression within A10 dopaminergic neurons. (Patel S, Hillard CJ) Brain Res 2003 Feb 14;963(1-2):15-25 58 Citations |
| 1 | Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. (Patel S, Hillard CJ) J Pharmacol Exp Ther 2001 May;297(2):629-37 82 Citations |
| 2 | Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. (Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ) J Neurochem 2000 Jun;74(6):2597-606 135 Citations |
| 2 | Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. (Muthian S, Nithipatikom K, Campbell WB, Hillard CJ) J Pharmacol Exp Ther 2000 Apr;293(1):289-95 33 Citations |
| 1 | Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. (Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ) J Neurochem 1999 Jun;72(6):2379-87 110 Citations |
| 2 | Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). (Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB) J Pharmacol Exp Ther 1999 Jun;289(3):1427-33 337 Citations |
| 1 | Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. (Diamond S, Pepper BJ, Diamond ML, Freitag FG, Urban GJ, Erdemoglu AK) Neurology 1998 Jul;51(1):274-6 18 Citations |
| 2 | Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. (Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ) J Pharmacol Exp Ther 1998 Jul;286(1):184-90 45 Citations |
| 1 | Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes. (Bloom AS, Edgemond WS, Moldvan JC) Neurochem Res 1997 May;22(5):563-8 36 Citations |
| 2 | Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. (Hillard CJ, Edgemond WS, Campbell WB) J Neurochem 1995 Feb;64(2):677-83 76 Citations |
© 2026 Clinical & Translational Science Institute